ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS)

CUSIP: 04962H506

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
129,337,627
Total 13F shares
16,001,766
Share change
-337,590
Total reported value
$20,161,211
Put/Call ratio
11%
Price per share
$1.26
Number of holders
48
Value change
-$384,693
Number of buys
20
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 04962H506?
CUSIP 04962H506 identifies ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
4.4%
5,697,536
$4,130,143 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
2.5%
3,204,531
$2,322,964 31 Mar 2023
13F
Laurion Capital Management LP
13F
Company
1.7%
2,225,800
$1,613,482 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.94%
1,210,885
$877,770 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.72%
936,070
$679,000 31 Mar 2023
13F
D. E. Shaw & Co., Inc.
13F
Company
0.64%
823,362
$596,855 31 Mar 2023
13F
STATE STREET CORP
13F
Company
0.37%
480,995
$348,673 31 Mar 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.36%
463,928
$336,000 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
0.17%
215,476
$156,199 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0.13%
170,755
$123,781 31 Mar 2023
13F
Bank of New York Mellon Corp
13F
Company
0.12%
151,280
$109,663 31 Mar 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.08%
105,642
$76,580 31 Mar 2023
13F
Mariner, LLC
13F
Company
0.08%
104,910
$76,000 31 Mar 2023
13F
SABBY MANAGEMENT, LLC
13F
Company
0.05%
65,714
$47,636 31 Mar 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.05%
64,247
$46,573 31 Mar 2023
13F
GROUP ONE TRADING LLC
13F
Company
0.05%
64,028
$46,414 31 Mar 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.05%
60,800
$44,074 31 Mar 2023
13F
EDMOND DE ROTHSCHILD HOLDING S.A.
13F
Company
0.04%
50,000
$36,245 31 Mar 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
45,962
$33,318 31 Mar 2023
13F
ETF MANAGERS GROUP, LLC
13F
Company
0.03%
42,442
$30,766 31 Mar 2023
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.03%
34,555
$25,000 31 Mar 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
22,561
$16,354 31 Mar 2023
13F
HighTower Advisors, LLC
13F
Company
0.02%
20,100
$15,000 31 Mar 2023
13F
FMR LLC
13F
Company
0.01%
15,604
$11,311 31 Mar 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
15,477
$11,205 31 Mar 2023
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.01%
14,186
$10,283 31 Mar 2023
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0.01%
12,600
$9,135 31 Mar 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
10,388
$8,000 31 Mar 2023
13F
J. L. Bainbridge & Co., Inc.
13F
Company
0.01%
10,621
$7,699 31 Mar 2023
13F
Cetera Advisor Networks LLC
13F
Company
0.01%
10,432
$7,562 31 Mar 2023
13F
LINCOLN NATIONAL CORP
13F
Company
0.01%
10,340
$7,495 31 Mar 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
5,023
$3,642 31 Mar 2023
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
4,555
$3,302 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
4,330
$3,135 31 Mar 2023
13F
HARBOUR INVESTMENTS, INC.
13F
Company
0%
1,711
$1,240 31 Mar 2023
13F
St. Johns Investment Management Company, LLC
13F
Company
0%
1,550
$1,124 31 Mar 2023
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0%
1,400
$1,000 31 Mar 2023
13F
TD Waterhouse Canada Inc.
13F
Company
0%
700
$524 31 Mar 2023
13F
Allworth Financial LP
13F
Company
0%
702
$509 31 Mar 2023
13F
Castleview Partners, LLC
13F
Company
0%
500
$362 31 Mar 2023
13F
Delos Wealth Advisors, LLC
13F
Company
0%
100
$73 31 Mar 2023
13F
Kyle Guse
3/4/5
CFO, Gen Counsel and Secretary
class O/S missing
557,900
02 Mar 2023

Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2023

As of 30 Jun 2023, ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,001,766 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Laurion Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MILLENNIUM MANAGEMENT LLC, GSA CAPITAL PARTNERS LLP, and D. E. Shaw & Co., Inc.. This page lists 48 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
41
Q2 2023 holders
48
Holder diff
7
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .